MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 66 filers reported holding MEREO BIOPHARMA GROUP PLC in Q2 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $304,535 | +6.2% | 84,593 | -2.6% | 0.00% | – |
| Q1 2024 | $286,681 | +1185.7% | 86,873 | +402.6% | 0.00% | – |
| Q3 2023 | $22,298 | -9.9% | 17,285 | -7.8% | 0.00% | – |
| Q2 2023 | $24,745 | -61.6% | 18,746 | -79.4% | 0.00% | – |
| Q1 2023 | $64,394 | -55.5% | 91,093 | -52.8% | 0.00% | – |
| Q4 2022 | $144,722 | -3.5% | 192,962 | +11.0% | 0.00% | – |
| Q3 2022 | $150,000 | +500.0% | 173,786 | +689.1% | 0.00% | – |
| Q2 2022 | $25,000 | -84.3% | 22,024 | -53.4% | 0.00% | – |
| Q1 2021 | $159,000 | +93.9% | 47,219 | +105.0% | 0.00% | – |
| Q4 2020 | $82,000 | – | 23,038 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tejara Capital Ltd | 2,435,806 | $1,721,871 | 0.88% |
| Monaco Asset Management SAM | 1,316,245 | $930,454 | 0.28% |
| DAFNA Capital Management LLC | 1,096,513 | $775,125 | 0.23% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,364,438 | $5,205,921 | 0.22% |
| Clearline Capital LP | 2,052,709 | $1,451,060 | 0.22% |
| Rubric Capital Management LP | 10,366,120 | $7,327,810 | 0.19% |
| Orbimed Advisors | 7,747,891 | $5,476,984 | 0.11% |
| Rock Springs Capital Management LP | 6,244,897 | $4,414,518 | 0.10% |
| 683 Capital Management, LLC | 2,000,000 | $1,413,801 | 0.10% |
| Privium Fund Management (UK) Ltd | 177,200 | $131,128 | 0.10% |